Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Document › Details

IDEX Health & Science LLC. (4/7/15). "Press Release: IDEX Health & Science Announces New Leadership and Market Segmentation". Rohnert Park, CA.

Organisation Organisation IDEX Health & Science LLC
  Group IDEX Corporation (Group)
Products Product analytical instrument
  Product 2 in vitro diagnostics (IVD)
Person Person Salem, Gustavo (Gus) (IDEX 201605 Group President of IDEX Health & Science before Siscapa + Agilent + Assay Designs)

New President joins IDEX Health & Science as it segments its focus towards Analytical Instruments and InVitro Diagnostics / Biotechnology Markets

On March 2, 2015 IDEX Health & Science, a division of IDEX Corporation’s (NYSE:IEX) Health & Science Technologies, announced Gustavo “Gus” Salem as the new President. Gus Salem has over 25 years of extensive experience in the life science industry, including his background as President and CEO of SISCAPA Assay Technologies, and Vice President and General Manager of the Biological Systems Division at Agilent Technologies.

Salem is an established leader in mass spectrometry, analytical instruments, IVD diagnostics and consumables markets, both in regards to customers, as well as large portfolios of products. He received his undergraduate degree in Physiological Psychology from the University of California at Berkeley.

In addition to this new leadership announcement, IDEX Health & Science is pleased to report its recent segmentation into two distinct businesses: Analytical Instruments and In Vitro Diagnostics / Biotechnology. The Analytical Instruments business will serve the non-clinical analytical instrument market, while the IVD/Biotech business will serve clinical OEM instrumentation manufacturers. This realignment into two key sectors will help to reinforce a targeted marketing strategy and increase product differentiation.

IDEX Health & Science looks forward to a new phase of growth as it continues to identify opportunities to maximize its influence and expansion in fluidic, IVD and diagnostics markets. These structural changes reinforce a commitment to product innovation that will more precisely meet customers’ needs and better leverage IDEX Health & Science’s exceptional portfolio of fluidic products and applied technologies.

About IDEX Health & Science LLC

IDEX Health & Science offers a three-fold advantage to its customers by bringing life to fluidic pathways with products, people, and engineering expertise. These integrated assets work seamlessly together to enable fluidic pathways beyond a combination of components, which collectively position IDEX Health & Science as the forerunner in biotechnology and life science fluidics. Known as industry leaders in the design, development, and manufacturing of liquid subassemblies, fluidic products and related sub-systems, IDEX Health & Science provides the best solution for analytical, diagnostic, and biotech instruments. Product offerings include: fluidic connections, valves, pumps, degassers, column hardware, manifolds, and customized assemblies. For more information visit:


Record changed: 2016-05-14


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for IDEX Corporation (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

» top